Claudio A. Zavaglia - Publications

Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: February 19, 2021

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.

Journal: Gut

Published: November 25, 2020

Pulmonary Resection for Metastasis of Hepatocellular Carcinoma Recurring After Liver Transplant: An Italian Multicenter Experience.

Journal: Frontiers in oncology

Published: September 19, 2019

Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation.

Journal: Transplantation

Published: September 14, 2019

Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 24, 2019

Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?

Journal: Journal of hepatology

Published: August 02, 2016

Autoimmunity after liver transplantation: a frequent event but a rare clinical problem.

Journal: Clinical transplantation

Published: December 10, 2014

Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysis.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 25, 2014

Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: does mTOR inhibitors association augment toxicity?

Journal: European journal of gastroenterology & hepatology

Published: April 04, 2014

Letter: Sorafenib hepatotoxicity may be enhanced during treatment of advanced hepatocellular carcinoma in HIV-infected patients.

Journal: Alimentary pharmacology & therapeutics

Published: October 02, 2013

Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue.

Journal: Journal of hepatology

Published: September 26, 2013

Prognostic factors of hepatic decompensation and hepatocellular carcinoma in patients with transfusion-acquired HCV infection.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 18, 2013